You have 7 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pegylated interferon alfa-2b

Showing 26 - 50 of 6,096
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Chronic Trial in Guangzhou (pegylated interferon-alfa)

Recruiting
  • Hepatitis B, Chronic
  • pegylated interferon-alfa
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Dec 20, 2021

Membranous Nephropathy Trial in Nice (Peginterferon Alfa-2A 180 MCG/ML Injectable Solution)

Not yet recruiting
  • Membranous Nephropathy
  • Peginterferon Alfa-2A 180 MCG/ML Injectable Solution
  • Nice, France
    CHU de NICE
Jul 4, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients

Recruiting
  • AIDS
  • Hepatitis B
  • Peginterferon alfa-2b Injection
  • Guangzhou, Guangdong, China
    Guangzhou Eighth People's Hospital, Guangzhou Medical University
Aug 10, 2023

COVID-19 Trial in Taipei (Ropeginterferon alfa-2b, SOC)

Not yet recruiting
  • COVID-19
  • Ropeginterferon alfa-2b
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 9, 2023

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Kidney Cancer Trial in New York (recombinant interferon alfa, tretinoin liposome)

Completed
Has Results
  • Kidney Cancer
  • recombinant interferon alfa
  • tretinoin liposome
  • New York, New York
  • +1 more
Mar 17, 2022

Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)

Active, not recruiting
  • Polycythemia Vera
  • San Giovanni Rotondo, (FG) Puglia, Italy
  • +22 more
Jan 10, 2023

COVID-19 Trial in Taipei (P1101 (Ropeginterferon alfa-2b), SOC)

Active, not recruiting
  • COVID-19
  • P1101 (Ropeginterferon alfa-2b)
  • SOC
  • Taipei, Taiwan
    National Taiwan University Hospital
Mar 13, 2023

Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

Withdrawn
  • Chronic Hepatitis B
  • hepatitis B immune globulin (HBIg)
  • Pegylated interferon alfa (pegIFN)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 4, 2022

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

HPV Infection Trial (Human interferon alpha 2b vaginal Effervescent capsules)

Not yet recruiting
  • HPV Infection
  • Human interferon alpha 2b vaginal Effervescent capsules
  • (no location specified)
May 8, 2023

Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

Completed
  • Chronic Hepatitis b
  • Vitamin D
  • Guangzhou, Guangdong, China
    Department of Infectious Diseases, The Third Affliated Hospital
Mar 2, 2023

Essential Thrombocythemia Trial (Bomedemstat, Anagrelide, Busulfan)

Not yet recruiting
  • Essential Thrombocythemia
  • (no location specified)
Oct 6, 2023

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Herpes Zoster Trial (Recombinant Human Interferon a-2b Gel (After the Alteration), Recombinant Human Interferon a-2b Gel (Before

Not yet recruiting
  • Herpes Zoster
  • Recombinant Human Interferon α-2b Gel (After the Alteration)
  • Recombinant Human Interferon α-2b Gel (Before the Alteration)
  • (no location specified)
Apr 7, 2023

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Hepatitis B, Chronic Trial in Beijing (Hepalatide 2.1mg, Hepalatide 4.2mg, Hepalatide 6.3mg)

Recruiting
  • Hepatitis B, Chronic
  • Hepalatide 2.1mg
  • +6 more
  • Beijing, Beijing, China
    The fifth medical center of PLA
Nov 23, 2021

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Pediatric Immuno-Tolerant Chronic Hepatitis B Trial in Worldwide (Entecavir, Lamivudine, Pegylated Interferon Alfa-2A)

Completed
Has Results
  • Pediatric Immuno-Tolerant Chronic Hepatitis B
  • Kansas City, Missouri
  • +24 more
Aug 21, 2020

Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

Completed
Has Results
  • Hepatitis D, Chronic
  • Peginterferon Lambda-1A
  • Beersheba, Israel
  • +3 more
Dec 20, 2022